Oracle Surges on $300 Billion OpenAI Deal
Oracle (NYSE: ORCL) just shocked the market after its shares jumped 45 percent in a single day, adding US$100 billion to Larry Ellison's fortune and briefly placing him ahead of Elon Musk. The catalyst was a US$300 billion contract with OpenAI to secure cloud computing power over the…
Tech Stocks
Test text
SenSen Networks: Solid Wins, Tough Market Reaction
SenSen Networks (ASX: SNS) opened sharply lower today, even after announcing fresh contract wins worth a combined AUD 2 million in FY26. The stock’s 23 percent drop has left many investors questioning why good news translated into heavy selling.
On paper, the update looked strong. SenSen secured a…
Telix Pharmaceuticals Gains FDA Clarity on Glioma Imaging Agent
Telix Pharmaceuticals (ASX: TLX) has given investors reason to sit up and take notice. The company announced it has reached agreement with the U.S. Food and Drug Administration on the resubmission of its new drug application for TLX101-CDx (Pixclara), an imaging agent designed for glioma. What…
How Investors Can Ride the Next Wave of AI Growth
NVIDIA (NSDQ: NVDA) has become the face of the artificial intelligence boom, riding a wave of explosive growth as companies pour hundreds of billions of dollars into building the infrastructure behind AI. But for retail investors, the story is bigger than just one stock. AI…
Our longer term readers would know we are big fans of Weebit Nano (ASX:WBT), a company commercialising its own version of a technology known as ReRAM (Resistive Random-Access Memory). We've spoken a lot about Weebit and certain other chip stocks embracing it (which we'll get into shortly), but we've never written an article focused on…
Imricor Medical Systems (ASX:IMR) is one of a handful of radiology stocks on the ASX, seeking to emulate the success of Pro Medicus (ASX:PME). There's no shortage of peers including Curvebeam AI (ASX:CVB), Resonance Health (ASX:RHT) and 4D Medical (ASX:4DX). But Imricor just might be the dark horse and we're going to tell you why.
What…
Why the Global X FANG+ ETF (ASX: FANG) Could Be a Growth Investor’s Shortcut to Innovation
Global X FANG+ ETF (ASX: FANG) gives investors a front row seat to some of the most powerful companies driving global markets today. Instead of trying to handpick the next winner among Apple, Microsoft, NVIDIA, or Tesla, this ETF…
Argenica Therapeutics Just Faced Its Toughest Test — What Comes Next
Argenica Therapeutics Ltd (ASX: AGN) has been thrown into the spotlight after its phase 2 trial results for ARG-007 sparked a brutal sell-off, sending the share price tumbling more than 60 percent in a single day. For investors, that kind of market reaction is…
Nanoveu Soars 25% on Drone Breakthrough
Nanoveu (ASX: NVU) caught the market’s attention today with a 25 percent surge after its EMASS subsidiary announced a breakthrough in drone technology. At the heart of the news is the company’s ECS Dot Edge AI Chip, which has shown the ability to extend drone flight endurance by an…
You might think ASX stocks in America are doing better than peers which are not there because the USA is a much bigger market. In reality, this is not always the case.
What are the Best ASX Stocks to invest in right now?
Check our buy/sell tips
[sg_popup id="23914" event="click"][/sg_popup]
ASX stocks in America: Here are 4 performing…
